Dietary Indole-3-Carbinol Alleviated Spleen Enlargement, Enhanced IgG Response in C3H/HeN Mice Infected with Citrobacter rodentium
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dietary Indole-3-Carbinol Alleviated Spleen Enlargement, Enhanced IgG Response in C3H/HeN Mice Infected with Citrobacter rodentium
Authors
Keywords
-
Journal
Nutrients
Volume 12, Issue 10, Pages 3148
Publisher
MDPI AG
Online
2020-10-15
DOI
10.3390/nu12103148
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indole-3-Carbinol Inhibits Citrobacter rodentium Infection through Multiple Pathways Including Reduction of Bacterial Adhesion and Enhancement of Cytotoxic T Cell Activity
- (2020) Yanbei Wu et al. Nutrients
- Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options
- (2016) Elizabeth Cerceo et al. Microbial Drug Resistance
- Cytokines IL-17 and IL-22 in the host response to infection
- (2016) Maria Valeri et al. Pathogens and Disease
- Global dissemination of a multidrug resistant Escherichia coli clone
- (2014) N. K. Petty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypervirulent-Host-Associated Citrobacter rodentium Cells Have Poor Acid Tolerance
- (2013) Allen Smith et al. CURRENT MICROBIOLOGY
- Group 3 Innate Lymphoid Cells Inhibit T-Cell-Mediated Intestinal Inflammation through Aryl Hydrocarbon Receptor Signaling and Regulation of Microflora
- (2013) Ju Qiu et al. IMMUNITY
- Intestinal monocytes and macrophages are required for T cell polarization in response toCitrobacter rodentium
- (2013) Heidi A. Schreiber et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Utility of a bacterial infection model to study epithelial–mesenchymal transition, mesenchymal–epithelial transition or tumorigenesis
- (2013) P Chandrakesan et al. ONCOGENE
- R-Spondin 2 signalling mediates susceptibility to fatal infectious diarrhoea
- (2013) Olivier Papapietro et al. Nature Communications
- Enteropathogenic and enterohemorrhagic E. coli: ecology, pathogenesis, and evolution
- (2013) Elizabeth L. Hartland et al. Frontiers in Cellular and Infection Microbiology
- Natural Killer Cells Protect against Mucosal and Systemic Infection with the Enteric Pathogen Citrobacter rodentium
- (2012) Lindsay J. Hall et al. INFECTION AND IMMUNITY
- Long-term Selenium Deficiency Increases the Pathogenicity of a Citrobacter rodentium Infection in Mice
- (2011) Allen D. Smith et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium
- (2011) Naruhisa Ota et al. NATURE IMMUNOLOGY
- Identification of an innate T helper type 17 response to intestinal bacterial pathogens
- (2011) Kaoru Geddes et al. NATURE MEDICINE
- Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles
- (2011) E. A. Kiss et al. SCIENCE
- Utility of the Citrobacter rodentium infection model in laboratory mice
- (2009) Diana Borenshtein et al. CURRENT OPINION IN GASTROENTEROLOGY
- The Citrobacter rodentium Genome Sequence Reveals Convergent Evolution with Human Pathogenic Escherichia coli
- (2009) N. K. Petty et al. JOURNAL OF BACTERIOLOGY
- Dose-Dependent Inhibition of Tobacco Smoke Carcinogen-Induced Lung Tumorigenesis in A/J Mice by Indole-3-Carbinol
- (2008) F. Kassie et al. Cancer Prevention Research
- Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells
- (2008) Marc Veldhoen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
- (2008) Yan Zheng et al. NATURE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started